Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk
Mayo Clinic
Mayo Clinic
Mayo Clinic
Dana-Farber Cancer Institute
Wake Forest University Health Sciences
University of Texas Southwestern Medical Center
SWOG Cancer Research Network
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Virginia Commonwealth University
Vanderbilt-Ingram Cancer Center